Search

everythinglearnresearchcommunity

for

Search:↓

Advanced human skin models improve drug development and could replace animal testing.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Ultrasonography in dermatology improves diagnosis and treatment of skin conditions.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Stem cells show promise for treating skin conditions and aiding healing.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Licorice has many health benefits but more research is needed to fully understand them.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Upadacitinib effectively treats psoriasis and lichen planus together.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

More research is needed to confirm the potential of various treatments, including Helichrysum plicatum, vitamins, bromelain, personalized medications, hydrogels, and bacteriophage therapy.

Panchakarma detoxifies the body, balances doshas, and is more effective than modern medicine alone for toxin removal and cell rejuvenation.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Skin symptoms can indicate endocrine disorders and have various treatments.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.